{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T19:35:02Z","timestamp":1764617702222,"version":"3.46.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Mannheim der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fever or inflammation state may enhance the Brugada syndrome (BrS) phenotype in some but not all patients. However, the underlying mechanism in human cardiomyocytes has not yet been clarified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Human induced pluripotent stem cell (hiPSC) lines generated from fibroblasts of three BrS patients harboring variants in\n                      <jats:italic>SCN10A<\/jats:italic>\n                      (abbreviated as BrS1) and\n                      <jats:italic>CACNB2<\/jats:italic>\n                      (abbreviated as BrS2),\n                      <jats:italic>SCN5A<\/jats:italic>\n                      (abbreviated as BrS3) and one healthy donor (abbreviated as WT) and a site-corrected (using CRISPR\/Cas9) hiPSC line of each BrS patient (abbreviated as isogenic1, isogenic2 and isogenic3) were used for differentiation into cardiomyocytes (hiPSC-CMs). Western blot, patch clamp and calcium transient analyses were carried out.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All 3 BrS cell lines showed a significantly reduced peak sodium current (I\n                      <jats:sub>Na<\/jats:sub>\n                      ) compared with isogenic or WT cells at baseline. Hyperthermia challenge (40\u00a0\u00b0C) significantly decreased I\n                      <jats:sub>Na<\/jats:sub>\n                      and enhanced arrhythmogeneity in BrS1 and BrS3 but not in BrS2 cells. The hyperthermia effects involved PKA reduction. The lipopolysaccharide (LPS) challenge exacerbated the phenotype in electrophysiological characteristics in all 3 BrS cell lines. ROS-Blocker abolished the LPS effects in all BrS hiPSC-CMs, while an interleukin-6 receptor blocker abolished the proarrhythmic effect of LPS in BrS1 and BrS3 hiPSC-CMs but not in hiPSC-CMs of BrS2.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hyperthermia exacerbated the BrS phenotype in hiPSC-CMs carrying SCN10A and SCN5A variants, whereas LPS aggravated the phenotype in all three BrS variants through distinct mechanisms; Hyperthermia and LPS effects on BrS phenotype may be genotype-dependent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-025-04793-6","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:44:14Z","timestamp":1764611054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypes in Brugada syndrome with different genotypes triggered by fever or inflammation using gene-edited iPSCs"],"prefix":"10.1186","volume":"16","author":[{"given":"Yingrui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Pr\u00e4del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Kleinsorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenghui","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Dinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra Viktoria","family":"Busley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rujia","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse","family":"Maywald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assem","family":"Aweimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Moscu-Gregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazha","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeweynwuha","family":"Zemedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saltanat","family":"Zhazykbayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Hohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"M\u00fcgge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Cyganek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-0127","authenticated-orcid":false,"given":"Xiaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"El-Battrawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"4793_CR1","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC). Endorsed by: association for European paediatric and congenital cardiology (AEPC). Eur Heart J. 2015;36:2793\u2013867.","journal-title":"Eur Heart J"},{"issue":"3","key":"4793_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/20009666.2020.1767278","volume":"10","author":"SS Roomi","year":"2020","unstructured":"Roomi SS, Ullah W, Abbas H, Abdullah H, Talib U, Figueredo V. Brugada syndrome unmasked by fever: a comprehensive review of literature. J Community Hosp Intern Med Perspect. 2020;10(3):224\u20138.","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"7","key":"4793_CR3","doi-asserted-by":"publisher","first-page":"e024410","DOI":"10.1161\/JAHA.121.024410","volume":"11","author":"Y Li","year":"2022","unstructured":"Li Y, Lang S, Akin I, Zhou X, El-Battrawy I. Brugada syndrome: different experimental models and the role of human cardiomyocytes from induced pluripotent stem cells. J Am Heart Assoc. 2022;11(7):e024410.","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"4793_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms21197155","volume":"21","author":"O Campuzano","year":"2020","unstructured":"Campuzano O, Sarquella-Brugada G, Cesar S, Arbelo E, Brugada J, Brugada R. Update on genetic basis of Brugada syndrome: Monogenic, polygenic or oligogenic? Int J Mol Sci. 2020;21(19):21.","journal-title":"Int J Mol Sci"},{"key":"4793_CR5","doi-asserted-by":"publisher","first-page":"e010595","DOI":"10.1161\/JAHA.118.010595","volume":"7","author":"PE Lazzerini","year":"2018","unstructured":"Lazzerini PE, Capecchi PL, El-Sherif N, et al. Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies. J Am Heart Assoc. 2018;7:e010595.","journal-title":"J Am Heart Assoc"},{"key":"4793_CR6","doi-asserted-by":"publisher","first-page":"e008627","DOI":"10.1161\/CIRCEP.120.008627","volume":"13","author":"PE Lazzerini","year":"2020","unstructured":"Lazzerini PE, Acampa M, Laghi-Pasini F, et al. Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via Cytokine-Mediated effects on potassium channel expression. Circ Arrhythm Electrophysiol. 2020;13:e008627.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"4793_CR7","first-page":"e18578","volume":"13","author":"S Ayad","year":"2021","unstructured":"Ayad S, Alyacoub R, Gergis K, et al. Fever and hyponatremia unmasking Brugada pattern electrocardiogram in a patient with SARS-CoV-2 infection. Cureus. 2021;13(10):e18578.","journal-title":"Cureus"},{"issue":"9","key":"4793_CR8","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.hrthm.2009.05.016","volume":"6","author":"K Samani","year":"2009","unstructured":"Samani K, Wu G, Ai T, Shuraih M, Mathuria NS, Li Z, et al. A novel SCN5A variant V1340I in Brugada syndrome augmenting arrhythmias during febrile illness. Heart Rhythm. 2009;6(9):1318\u201326.","journal-title":"Heart Rhythm"},{"key":"4793_CR9","doi-asserted-by":"crossref","unstructured":"Bonny A, Tonet J, Marquez MF, De Sisti A, Temfemo A, Himbert C, Gueffaf F, Larrazet F, Ditah I, Frank R, Hidden-Lucet F, Fontaine G. C-reactive protein levels in the brugada syndrome. Cardiol Res Pract. 2011; 2011:341521.","DOI":"10.4061\/2011\/341521"},{"key":"4793_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.hrcr.2017.04.011","volume":"3","author":"A Li","year":"2017","unstructured":"Li A, Tung R, Shivkumar K, Bradfield JS. Brugada syndrome-Malignant phenotype associated with acute cardiac inflammation? HeartRhythm Case Rep. 2017;3:384\u20138.","journal-title":"HeartRhythm Case Rep"},{"issue":"10229","key":"4793_CR11","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"T Fei Zhou","year":"2020","unstructured":"Fei Zhou T, Yu R, Du, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, china: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"1","key":"4793_CR12","first-page":"37","volume":"5","author":"H Jin","year":"2020","unstructured":"Jin H, Yang S, He P, Weng H, Liu S, Yang F, et al. Serum procalcitonin levels on admission predict death in severe and critical COVID-19 patients in Wuhan, China. Cardiovasc Innov Appl. 2020;5(1):37\u201344.","journal-title":"Cardiovasc Innov Appl"},{"key":"4793_CR13","doi-asserted-by":"publisher","first-page":"e0208321","DOI":"10.1371\/journal.pone.0208321","volume":"13","author":"AS Aromolaran","year":"2018","unstructured":"Aromolaran AS, et al. Interleukin-6 Inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation. PLoS ONE. 2018;13:e0208321.","journal-title":"PLoS ONE"},{"key":"4793_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41577-018-0098-z","volume":"19","author":"PE Lazzerini","year":"2019","unstructured":"Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;19:63\u20134.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4793_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41598-022-04852-5","volume":"12","author":"X Zhu","year":"2022","unstructured":"Zhu X, Wang Y. Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and Azithromycin in inflammatory diseases. Sci Rep. 2022;12(1):1075.","journal-title":"Sci Rep"},{"issue":"4","key":"4793_CR16","first-page":"119","volume":"9","author":"Y Zhenxing Liao","year":"2022","unstructured":"Zhenxing Liao Y, Li X, Yang FZ, El-Battrawy I, Zhou X, et al. Lipopolysaccharide modifies sodium current kinetics through ROS and PKC signalling in induced pluripotent Stem-Derived cardiomyocytes from Brugada syndrome patient. J Cardiovasc Dev Dis. 2022;9(4):119.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"3","key":"4793_CR17","doi-asserted-by":"publisher","first-page":"e1130","DOI":"10.1002\/ctm2.1130","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Dinkel H, Pakalniskyte D, et al. Novel insights in the pathomechanism of Brugada syndrome and fever-related type 1 ECG changes in a preclinical study using human-induced pluripotent stem cell-derived cardiomyocytes. Clin Transl Med. 2023;13(3):e1130.","journal-title":"Clin Transl Med"},{"key":"4793_CR18","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.3390\/ijms23158507","volume":"23","author":"X Fan","year":"2022","unstructured":"Fan X, Cyganek L, Nitschke K, Uhlig S, Nuhn P, Bieback K, et al. Functional characterization of human induced pluripotent stem Cell-Derived endothelial cells. Int J Mol Sci. 2022;23:8507.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4793_CR19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/europace\/euz122","volume":"21","author":"IE-BS Albers","year":"2019","unstructured":"Albers IE-BS, Cyganek L, Zhao Z, Lan H, Li X, et al. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes. Europace. 2019;21(9):1410\u201321.","journal-title":"Europace"},{"key":"4793_CR20","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.3390\/ijms23158313","volume":"23","author":"R Zhong","year":"2022","unstructured":"Zhong R, Schimanski T, Zhang F, Lan H, Hohn A, Xu Q, et al. A preclinical study on Brugada syndrome with a CACNB2 variant using human cardiomyocytes from induced pluripotent stem cells. Int J Mol Sci. 2022;23:8313.","journal-title":"Int J Mol Sci"},{"key":"4793_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1161\/CIRCULATIONAHA.119.044794","volume":"142","author":"U Hanses","year":"2020","unstructured":"Hanses U, Kleinsorge M, Roos L, Yigit G, Li Y, Barbarics B, et al. Intronic CRISPR repair in a preclinical model of Noonan Syndrome-Associated cardiomyopathy. Circulation. 2020;142:1059\u201376.","journal-title":"Circulation"},{"key":"4793_CR22","doi-asserted-by":"publisher","first-page":"100026","DOI":"10.1016\/j.xpro.2020.100026","volume":"1","author":"M Kleinsorge","year":"2020","unstructured":"Kleinsorge M, Cyganek L. Subtype-Directed differentiation of human iPSCs into atrial and ventricular cardiomyocytes. STAR Protoc. 2020;1:100026.","journal-title":"STAR Protoc"},{"issue":"12","key":"4793_CR23","doi-asserted-by":"publisher","first-page":"e646","DOI":"10.1002\/ctm2.646","volume":"11","author":"IE-BH Lan","year":"2021","unstructured":"Lan IE-BH, Cyganek L, Maywald L, Zhong R, Zhang F, et al. Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screening. Clin Transl Med. 2021;11(12):e646.","journal-title":"Clin Transl Med"},{"key":"4793_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/713609356","volume":"40","author":"WT Clusin","year":"2003","unstructured":"Clusin WT. Calcium and cardiac arrhythmias: DADs, EADs, and alternans. Crit Rev Clin Lab Sci. 2003;40:337\u201375.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"4793_CR25","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.jacc.2016.07.779","volume":"68","author":"P Liang","year":"2016","unstructured":"Liang P, Sallam K, Wu H, et al. Patient-Specific and Genome-Edited induced pluripotent stem Cell-Derived cardiomyocytes elucidate Single-Cell phenotype of Brugada syndrome. J Am Coll Cardiol. 2016;68:2086\u201396.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4793_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/humu.23730","volume":"40","author":"G Oscar Campuzano","year":"2019","unstructured":"Oscar Campuzano G, Sarquella-Brugada A, Fernandez-Falgueras, et al. Genetic interpretation and clinical translation of minor genes related to Brugada syndrome. Hum Mutat. 2019;40(6):749\u201364.","journal-title":"Hum Mutat"},{"issue":"4","key":"4793_CR27","doi-asserted-by":"publisher","first-page":"e2871","DOI":"10.1016\/j.repc.2014.10.002","volume":"34","author":"M Madeira","year":"2015","unstructured":"Madeira M, Caetano F, Providencia R, et al. Fever induced type 1 Brugada pattern. Rev Port Cardiol. 2015;34(4):e2871\u20137.","journal-title":"Rev Port Cardiol"},{"issue":"7","key":"4793_CR28","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.hrthm.2016.03.044","volume":"13","author":"Y Mizusawa","year":"2016","unstructured":"Mizusawa Y, Morita H, Adler A, et al. Prognostic significance of fever-induced Brugada syndrome. Heart Rhythm. 2016;13(7):1515\u201320.","journal-title":"Heart Rhythm"},{"key":"4793_CR29","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/01.RES.85.9.803","volume":"85","author":"R Dumaine","year":"1999","unstructured":"Dumaine R, Towbin JA, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res. 1999;85:803\u20139.","journal-title":"Circ Res"},{"key":"4793_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.hrcr.2020.03.012","volume":"6","author":"D Chang","year":"2020","unstructured":"Chang D, Saleh M, Garcia-Bengo M, et al. COVID-19 infection unmasking Brugada syndrome. HeartRhythm Case Rep. 2020;6:237\u201340.","journal-title":"HeartRhythm Case Rep"},{"key":"4793_CR31","doi-asserted-by":"crossref","unstructured":"Sorgente A, Capulzini L, Brugada P. The known into the unknown: Brugada syndrome and COVID-19. JACC Case Rep. 2020, Epublished.","DOI":"10.1016\/j.jaccas.2020.04.006"},{"key":"4793_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/01.RES.80.3.370","volume":"80","author":"KT Murray","year":"1997","unstructured":"Murray KT, Hu N, Daw JR, Shin HG, Watson MT, Mashburn AB, George AL Jr. Functional effects of protein kinase C activation on the human cardiac Na\u2009+\u2009channel. Circ Res. 1997;80:370\u20136.","journal-title":"Circ Res"},{"key":"4793_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/01.RES.87.1.33","volume":"87","author":"J Zhou","year":"2000","unstructured":"Zhou J, Yi J, Hu N, George AL Jr, Murray KT. Activation of protein kinase A modulates trafficking of the human cardiac sodium channel in xenopus oocytes. Circ Res. 2000;87:33\u20138.","journal-title":"Circ Res"},{"issue":"1","key":"4793_CR34","first-page":"1599","volume":"17","author":"D Bao","year":"2018","unstructured":"Bao D, Zhao W, Dai C, et al. H89 dihydrochloride hydrate and Calphostin C lower the body temperature through TRPV1. Mol Med Rep. 2018;17(1):1599\u2013608.","journal-title":"Mol Med Rep"},{"key":"4793_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41577-018-0098-z","volume":"19","author":"PE Lazzerini","year":"2019","unstructured":"Lazzerini PE, Laghi-Pasini F, Boutjdir M, et al. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;19:63\u20134.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"4793_CR36","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/CIRCRESAHA.110.220673","volume":"107","author":"H Man Liu","year":"2010","unstructured":"Man Liu H, Liu SC, Dudley Jr. Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circ Res. 2010;107(8):967\u201374.","journal-title":"Circ Res"},{"issue":"1","key":"4793_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10787-020-00773-9","volume":"29","author":"A Hariharan","year":"2021","unstructured":"Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M. The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients. Inflammopharmacology. 2021;29(1):91\u2013100.","journal-title":"Inflammopharmacology"},{"issue":"22","key":"4793_CR38","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1136\/heartjnl-2016-311079","volume":"103","author":"PE Lazzerini","year":"2017","unstructured":"Lazzerini PE, et al. Systemic inflammation as a novel QT-prolonging risk factor in patients with Torsades de pointes. Heart. 2017;103(22):1821\u20139.","journal-title":"Heart"},{"issue":"22","key":"4793_CR39","doi-asserted-by":"publisher","first-page":"e010595","DOI":"10.1161\/JAHA.118.010595","volume":"7","author":"PE Lazzerini","year":"2018","unstructured":"Lazzerini PE, Capecchi PL, El-Sherif N, Laghi-Pasini F, Boutjdir M. Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies. J Am Heart Assoc. 2018;7(22):e010595.","journal-title":"J Am Heart Assoc"},{"key":"4793_CR40","first-page":"165","volume":"5","author":"J Li","year":"2021","unstructured":"Li J, Sun L, Wang F, Liu B, Li H, Tang G, et al. Relation between cardiac injury and elevated levels of inflammatory biomarkers in patients with severe COVID-19. Cardiovasc Innov Appl. 2021;5:165\u201372.","journal-title":"Cardiovasc Innov Appl"},{"key":"4793_CR41","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","volume":"8","author":"S Rose-John","year":"2012","unstructured":"Rose-John S, et al. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci. 2012;8:1237\u201347.","journal-title":"Int J Biol Sci"},{"key":"4793_CR42","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878\u201388.","journal-title":"Biochim Biophys Acta"},{"key":"4793_CR43","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1172\/JCI57158","volume":"121","author":"SA Jones","year":"2011","unstructured":"Jones SA, Scheller J, Rose-John S, et al. Therapeutic strategies for the clinical Blockade of IL-6\/gp130 signaling. J Clin Invest. 2011;121:3375\u201383.","journal-title":"J Clin Invest"},{"key":"4793_CR44","doi-asserted-by":"publisher","first-page":"8723","DOI":"10.1074\/jbc.272.13.8723","volume":"272","author":"Si Yamagishi","year":"1997","unstructured":"Yamagishi Si, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, et al. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chern. 1997;272:8723\u201330.","journal-title":"J Biol Chern"},{"key":"4793_CR45","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","volume":"50","author":"A Bierhaus","year":"2001","unstructured":"Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert P, Chen J, Hong M, Luther T, Henle T, Kl\u00f6ting I, et al. Diabetes associated sustained activation of the transcription factor nuclear factor kappa B. Diabetes. 2001;50:2792\u2013808.","journal-title":"Diabetes"},{"key":"4793_CR46","doi-asserted-by":"crossref","unstructured":"Vo TTT, Hsu C-Y. Yinshen Wee. Carbon Monoxide-Releasing Molecule-2 Ameliorates Particulate Matter-Induced Aorta Inflammation via Toll-Like Receptor\/NADPH Oxidase\/ROS\/NF- \u03ba B\/IL-6 Inhibition. Oxid Med Cell Longev. 2021; 2021:2855042.","DOI":"10.1155\/2021\/2855042"},{"issue":"6","key":"4793_CR47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/antiox9060491","volume":"9","author":"D Xiaoliang Dong","year":"2020","unstructured":"Xiaoliang Dong D, Wu Y, Zhang, et al. Cathelicidin modulates vascular smooth muscle cell phenotypic switching through ROS\/IL-6 pathway. Antioxid (Basel). 2020;9(6):491.","journal-title":"Antioxid (Basel)"},{"key":"4793_CR48","doi-asserted-by":"publisher","first-page":"e13210","DOI":"10.1111\/apha.13210","volume":"225","author":"SM Iqbal","year":"2019","unstructured":"Iqbal SM, Lemmens-Gruber R. Phosphorylation of cardiac voltage-gated sodium channel: potential players with multiple dimensions. Acta Physiol (Oxf). 2019;225:e13210.","journal-title":"Acta Physiol (Oxf)"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04793-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04793-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04793-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T19:02:08Z","timestamp":1764615728000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04793-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4793"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04793-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethik-Kommission II der Universit\u00e4t Heidelberg, Medizinische Fakult\u00e4t Mannheim (Investigation of the pathophysiology of cardiac arrhythmias using cardiomyocytes, vascular lining cells, nerve cells, and muscle cells from human induced pluripotent stem cells (hiPSCs) in various cardiovascular diseases, 2024\u2009\u2212\u2009573, July 9, 2024). The study was conducted based on the Declaration of Helsinki 1975 of the World Medical Association, as revised in 2013. Primary somatic cells used in this study were derived from skin biopsies or blood samples obtained after written informed consent had been provided by patients\u2019 authorized representatives for both research participation and sample utilization.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"670"}}